Sue E. Leurgans had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.
A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease
Version of Record online: 27 MAR 2013
Copyright © 2013 Movement Disorder Society
Volume 28, Issue 9, pages 1230–1240, August 2013
How to Cite
Corcos, D. M., Robichaud, J. A., David, F. J., Leurgans, S. E., Vaillancourt, D. E., Poon, C., Rafferty, M. R., Kohrt, W. M. and Comella, C. L. (2013), A two-year randomized controlled trial of progressive resistance exercise for Parkinson's disease. Mov. Disord., 28: 1230–1240. doi: 10.1002/mds.25380
Funding agencies: Supported by grant R01-NS28127-12 to 16 from the National Institute of Neurological Disorders and Stroke.
Relevant conflicts of interest/financial disclosures: DMC received grant support from NIH and Michael J. Fox, and receives lecture and reviewer fees from NIH. JAR, FJD, and CP received grant support from NIH. SEL was a statistical consultant for this project through the University of Illinios at Chicago. DEV receives grant support from NIH, Michael J. Fox, and consults for projects at UT Southwestern Medical Center and Great Lakes NeuroTechnologies. MRR has scholarship support from the Foundation for Physical Therapy and received grant support from NIH. WMK receives grant support from NIH and DoD and consulting fees from NIH. CLC is or has received research support from Allergan Inc., Merz Pharmaceuticals, Ipsen Limited , NIH, and Parkinson Disease Foundation and consulting fees from Neupathe, Allergan Inc., Merz Pharmaceuticals, Ipsen Limited and Medtronic Corporation.
Full financial disclosures and author roles may be found in the online version of this article.
The sponsors were not involved in the design, conduct, collection, management, analysis, and/or interpretation of the study results and preparation, review, or approval of the article.
The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the National Institute of Neurological Disorders and Stroke.
- Issue online: 3 SEP 2013
- Version of Record online: 27 MAR 2013
- Manuscript Accepted: 3 JAN 2013
- Manuscript Revised: 22 DEC 2012
- Manuscript Received: 12 SEP 2012
Options for accessing this content:
- If you are a society or association member and require assistance with obtaining online access instructions please contact our Journal Customer Services team.
- If your institution does not currently subscribe to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!
Patients and/or caregivers may access this content for use in relation to their own personal healthcare or that of a family member only. Terms and conditions will apply.